Momentum

Low Prevalence of Unsuppressed Viral Load among Gay and Bisexual Men Living with HIV in Vancouver: BC-CfE Momentum Study

93% of gay and bisexual men living with HIV are accessing HIV treatment, but additional strategies are needed to engage low-income and non-white men. What are the key study findings? Despite a high prevalence of HIV among gbMSM (23.4%), a small proportion of HIV-positive study participants (18.6%) had unsuppressed viral load (≥200 copies/ml), which is

Low Prevalence of Unsuppressed Viral Load among Gay and Bisexual Men Living with HIV in Vancouver: BC-CfE Momentum Study Read More »

Canadian researchers from Sex Now, Momentum and other studies weigh in

A surge of government-funded studies into HIV and the health of gay and bisexual men marks a new recognition among public health officials of the community’s needs, say some researchers. “Gay and bisexual men have been largely neglected as a population within the HIV epidemic in the early 2000s,” says Olivier Ferlatte, a researcher with

Canadian researchers from Sex Now, Momentum and other studies weigh in Read More »

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below